Related Experiment Video
Updated: Jan 19, 2026

10:02
Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
Published on: December 19, 2025
282
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers
S Alfieri1, S Rota1, R Romanò1
1Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
ESMO Open
|January 17, 2026
Summary
This study developed a molecular profiling algorithm for salivary gland cancers (SGCs) to guide treatment. The histology-driven approach optimizes testing for rare SGCs, improving therapeutic decisions.
Area of Science:
- Oncology
- Genomics
- Translational Research
Background:
- Salivary gland cancers (SGCs) are rare and diverse malignancies with limited treatment options.
- Optimizing molecular profiling (MP) strategies is crucial for effective therapeutic decision-making in SGCs.
Purpose of the Study:
- To define a histology-driven molecular profiling (MP) algorithm for SGCs.
- To optimize testing strategies and support therapeutic decisions for SGC patients.
Main Methods:
- Retrospective analysis of 253 SGC patients undergoing MP (2016-2023).
- Utilized DNA/RNA next-generation sequencing (NGS), immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH) for gene rearrangements and variants.
- Classified SGCs into adenoid cystic carcinomas (AdCCs) and non-AdCCs (low or high aggression).
Main Results:
- MYB/MYBL1 fusions identified in 47% of AdCCs; pathogenic/likely pathogenic variants (P-LPV) were rare.
- P-LPV found in 55% of high-aggression non-AdCCs (e.g., TP53, PIK3CA) and 50% of low-aggression non-AdCCs.
- HER2 positivity detected in 23% of high-aggression non-AdCCs; P-LPV rates varied by HER2 status and aggression level.
Conclusions:
- A tailored, histology-driven MP algorithm for SGCs is proposed.
- This algorithm can optimize genomic testing resources and guide clinical management.
- Supports the clinical implementation of MP for improved SGC patient care.

